Dosimetric comparison of MR-guided adaptive IMRT versus 3DOF-VMAT for prostate stereotactic radiotherapy

被引:1
|
作者
Kong, Vickie C. [1 ,2 ]
Dang, Jennifer [1 ]
Li, Winnie [1 ,2 ]
Navarro, Inmaculada [1 ,2 ]
Padayachee, Jerusha [1 ,2 ]
Malkov, Victor [1 ,2 ]
Winter, Jeff [1 ,2 ]
Raman, Srinivas [1 ,2 ]
Berlin, Alejandro [1 ,2 ]
Catton, Charles [1 ,2 ]
Warde, Padraig [1 ,2 ]
Chung, Peter [1 ,2 ]
机构
[1] Princess Margaret Canc Ctr, Radiat Med Program, Toronto, ON, Canada
[2] Univ Toronto, Dept Radiat Oncol, Toronto, ON, Canada
关键词
MR -guided adaptive radiotherapy; IMRT; VMAT; Prostate SBRT; VOLUMETRIC MODULATED ARC; BODY RADIOTHERAPY; PLAN QUALITY; CANCER; THERAPY; BRACHYTHERAPY;
D O I
10.1016/j.tipsro.2022.02.003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: To compare the dosimetry of prostate stereotactic radiotherapy (SBRT) delivered by adaptive intensity modulated radiotherapy (A-IMRT) and 3 degree of freedom volumetric modulated arc therapy (3DOF VMAT) Methods & Materials: Twenty-five prostate patients treated with High Dose Rate (HDR) brachytherapy followed by SBRT were included (fifteen with hydrogel spacer in place for treatment). Interfraction changes in the volume of prostate, rectum and bladder were measured. Fractional dose to these structures was estimated for A-IMRT and 3DOF-VMAT for comparison against the corresponding reference dose and between each other. Results: Clinically acceptable dose was delivered to prostate in all 125 fractions through A-IMRT and 3DOFVMAT. A-IMRT was better than 3DOF-VMAT in reducing dose to 1 cm3 of rectum. Conversely, 3DOF-VMAT was superior in sparing 50% and 20% of rectum. When comparing the reference and delivered dose, there was no significant difference for Bladder D5cm3 for either technique. However, rectum in the high dose region benefited more from A-IMRT by being irradiated to a lower than reference dose in more fractions than 3DOFVMAT. Hydrogel spacer reduced the rectal dose and was associated with a smaller deviation from reference dose for rectum D50% for A-IMRT. Conclusions: Despite the presence of large interfraction organ volumes changes, clinically acceptable dose was delivered to the prostate by both systems. A-IMRT facilitated a greater rectal sparing from the high dose region than 3DOF-VMAT. Further reduction in rectal dose could be achieved by hydrogel spacer to displace the rectum, or by adaptation delivered by VMAT.
引用
收藏
页码:64 / 70
页数:7
相关论文
共 50 条
  • [41] Plan Adaptation in Patients with Abdominopelvic Tumors Treated with Stereotactic MR-Guided Adaptive Radiotherapy
    Kotecha, R.
    Herrera, R.
    Chuong, M.
    Rubens, M.
    Mittauer, K.
    Romaguera, T.
    Alavrez, D.
    McCulloch, J.
    Doty, D.
    Hall, M.
    Contreras, J.
    Gutierrez, A.
    Mehta, M.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S384 - S384
  • [42] Retrospective evaluation of decision-making for pancreatic stereotactic MR-guided adaptive radiotherapy
    Tyran, Marguerite
    Jiang, Naomi
    Cao, Minsong
    Raldow, Ann
    Lamb, James M.
    Low, Daniel
    Luterstein, Elaine
    Steinberg, Michael L.
    Lee, Percy
    RADIOTHERAPY AND ONCOLOGY, 2018, 129 (02) : 319 - 325
  • [43] Phase I Trial of Stereotactic MR-guided Online Adaptive Radiotherapy for Ovarian Oligometastases
    Henke, L.
    Green, O.
    Curcuru, A.
    Mutic, S.
    Markovina, S.
    Schwarz, J.
    Grigsby, P.
    Robinson, C.
    Chundury, A.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S817 - S818
  • [44] Dosimetric Impact of Air Cavities in Gastrointestinal Tract for MR-Guided Stereotactic Body Radiotherapy of Pancreas Cancers
    Neylon, J.
    Wang, C.
    Lee, P.
    Du, D.
    Yang, Y.
    Lamb, J.
    Sheng, K.
    Agazaryan, N.
    Low, D.
    Cao, M.
    MEDICAL PHYSICS, 2017, 44 (06) : 3185 - 3185
  • [45] Dose accumulation for personalized stereotactic MR-guided adaptive radiation therapy in prostate cancer
    Bohoudi, Omar
    Bruynzeel, Anna M. E.
    Tetar, Shyama
    Slotman, Ben J.
    Palacios, Miguel A.
    Lagerwaard, Frank J.
    RADIOTHERAPY AND ONCOLOGY, 2021, 157 : 197 - 202
  • [46] Small Field Dosimetric Characterization of 7MV FFF Photons for Stereotactic MR-Guided Adaptive Radiotherapy Using the Unity MR-Linac
    Hwang, M.
    Chen, X.
    Oh, S.
    Lee, D.
    Pavord, D.
    Coopey, B.
    Sohn, J.
    MEDICAL PHYSICS, 2022, 49 (06) : E952 - E952
  • [47] Dosimetric comparison of MR-linac-based IMRT and conventional VMAT treatment plans for prostate cancer
    Mendes, Vanessa Da Silva
    Nierer, Lukas
    Li, Minglun
    Corradini, Stefanie
    Reiner, Michael
    Kamp, Florian
    Niyazi, Maximilian
    Kurz, Christopher
    Landry, Guillaume
    Belka, Claus
    RADIATION ONCOLOGY, 2021, 16 (01)
  • [48] Dosimetric comparison of MR-linac-based IMRT and conventional VMAT treatment plans for prostate cancer
    Vanessa Da Silva Mendes
    Lukas Nierer
    Minglun Li
    Stefanie Corradini
    Michael Reiner
    Florian Kamp
    Maximilian Niyazi
    Christopher Kurz
    Guillaume Landry
    Claus Belka
    Radiation Oncology, 16
  • [49] Feasibility of MR-guided stereotactic body radiotherapy in 5, 2 or 1 fractions for prostate cancer
    Mohajer, J.
    Dunlop, A.
    Mitchell, A.
    Nill, S.
    Oelfke, U.
    Tree, A.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S290 - S290
  • [50] Comparison of prostate delineation on multi-modality imaging for MR-guided radiotherapy
    Pathmanathan, A.
    Schmidt, M.
    Brand, D.
    Delacroix, L.
    Eccles, C.
    Gordon, A.
    Herbert, T.
    McNair, H.
    Van As, N.
    Huddart, R.
    Tree, A.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S868 - S869